One CEO said people should be using AI to understand their health much more than they already do.

Nuevocor, a biotechnology company that develops therapies for cardiomyopathies, has appointed Monica Shah, MD, as chief medical officer.  Dr. Shah is a heart failure and transplant cardiologist with ...

Immunic Inc. IMUX on Tuesday announced it appointed Michael Panzara as its Chief Medical Officer, effective April 24, 2026, as the company looks to advance its clinical and regulatory strategy. The ...

SINGAPORE, PARIS and PHILADELPHIA, April 28, 2026 /PRNewswire/ -- Nuevocor, a clinical-stage biotechnology company developing novel therapies for patients suffering from life-threatening ...

Immunic Inc (NASDAQ:IMUX, FRA:10VA) has named Michael A. Panzara as Chief Medical Officer, bringing aboard a veteran neurologist with more than 25 years of drug development experience as the ...

Erasca (ERAS) stock plummeted 50% following disappointing trial results for ERAS-0015, a patient death, and a patent lawsuit ...

Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference ...

Backed by improved patient outcomes and shorter recovery times, the technology is reshaping how procedures are performed—and ...

One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services remains relatively stable, regardless of market conditions.

Developed by China Medical University Hospital, Ever Supreme International Biotechnology Co., Ltd. and SHINE OUT BIO ...

It has been known for years by insiders as the “hidden gem” of North Carolina’s life sciences ecosystem. And now, after four ...